Validus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALIDUS PHARMS, and what generic alternatives to VALIDUS PHARMS drugs are available?
VALIDUS PHARMS has twenty-one approved drugs.
There is one US patent protecting VALIDUS PHARMS drugs.
There is one patent family member on VALIDUS PHARMS drugs in one country and ten supplementary protection certificates in six countries.
Summary for Validus Pharms
International Patents: | 1 |
US Patents: | 1 |
Tradenames: | 19 |
Ingredients: | 17 |
NDAs: | 21 |
Drugs and US Patents for Validus Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms | LASIX | furosemide | TABLET;ORAL | 016273-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | ||||
Validus Pharms | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 005010-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Validus Pharms | LOTENSIN | benazepril hydrochloride | TABLET;ORAL | 019851-002 | Jun 25, 1991 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | ||||
Validus Pharms | DEMEROL | meperidine hydrochloride | SYRUP;ORAL | 005010-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Validus Pharms | LOPRESSOR | metoprolol tartrate | TABLET;ORAL | 017963-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | ||||
Validus Pharms | CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-003 | May 20, 1985 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Validus Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | ROCALTROL | calcitriol | CAPSULE;ORAL | 018044-002 | Approved Prior to Jan 1, 1982 | 4,225,596 | See Plans and Pricing |
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-003 | Approved Prior to Jan 1, 1982 | 3,454,698 | See Plans and Pricing |
Validus Pharms | ROCALTROL | calcitriol | CAPSULE;ORAL | 018044-002 | Approved Prior to Jan 1, 1982 | 4,341,774 | See Plans and Pricing |
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-001 | Approved Prior to Jan 1, 1982 | 3,454,554 | See Plans and Pricing |
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-004 | Approved Prior to Jan 1, 1982 | 3,454,554 | See Plans and Pricing |
Validus Pharms | TRENTAL | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 018631-001 | Aug 30, 1984 | 4,189,469 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Capsules | 200 mg and 300 mg | ➤ Subscribe | 2007-08-21 |
➤ Subscribe | Extended-release Capsules | 100 mg | ➤ Subscribe | 2014-05-23 |
International Patents for Validus Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2452588 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Validus Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0454511 | 99C0009 | Belgium | See Plans and Pricing | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
0443983 | C00443983/03 | Switzerland | See Plans and Pricing | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0502314 | SPC/GB02/037 | United Kingdom | See Plans and Pricing | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
0266730 | C970043 | Netherlands | See Plans and Pricing | PRODUCT NAME: DOLASETRON, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; NAT REGISTRATION NO/DATE: RVG 21707 - RVG 21709 19970623; FIRST REGISTRATION: GB PL 04425/0150, PL 04425/0152, PL 04425/0154 19960926 |
0454511 | SPC/GB99/008 | United Kingdom | See Plans and Pricing | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
0565634 | 06C0030 | France | See Plans and Pricing | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.